Followers | 21 |
Posts | 3085 |
Boards Moderated | 0 |
Alias Born | 03/11/2010 |
Tuesday, October 02, 2018 9:47:41 AM
Recent LQDA News
- United States Supreme Court Declines to Review Rulings that Invalidate United Therapeutics’ Patent • GlobeNewswire Inc. • 10/07/2024 02:00:07 PM
- Liquidia and Pharmosa Biopharm Expand Collaboration to Develop Sustained Release Inhaled Treprostinil (L606) • GlobeNewswire Inc. • 10/02/2024 10:00:00 AM
- Liquidia Announces Poster Presentation and Medical Theater at the CHEST 2024 Annual Meeting • GlobeNewswire Inc. • 09/30/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/17/2024 09:15:21 PM
- Court Finds United Therapeutics’ Interference with Launch of Generic Treprostinil Injection Caused Losses of More Than $137 Million • GlobeNewswire Inc. • 09/16/2024 01:41:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/12/2024 08:01:17 PM
- Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 09/11/2024 08:41:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/11/2024 12:33:07 PM
- Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses • Edgar (US Regulatory) • 09/11/2024 12:29:55 PM
- Liquidia Corporation Announces Raise of $67.5 Million from New Common Stock Financings and $32.5 Million Advance from HealthCare Royalty Under Current Financing Agreement • GlobeNewswire Inc. • 09/11/2024 12:26:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/11/2024 12:08:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/04/2024 08:44:31 PM
- Liquidia to Present at Upcoming Investor Conferences • GlobeNewswire Inc. • 08/28/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/22/2024 10:31:14 AM
- Liquidia Files Litigation to Challenge Regulatory Exclusivity Blocking Access to YUTREPIA™ (treprostinil) inhalation powder for Patients Suffering with PAH and PH-ILD • GlobeNewswire Inc. • 08/22/2024 10:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/19/2024 11:00:32 AM
- U.S. FDA Grants Tentative Approval of YUTREPIA™ (treprostinil) Inhalation Powder for Patients with Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD) • GlobeNewswire Inc. • 08/19/2024 10:00:00 AM
- Liquidia Announces Poster Presentations at the PHA 2024 International PH Conference and Scientific Sessions • GlobeNewswire Inc. • 08/16/2024 10:30:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/07/2024 11:32:42 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2024 11:00:19 AM
- Liquidia Corporation Reports Second Quarter 2024 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 08/07/2024 10:30:00 AM
- Liquidia Corporation to Report Second Quarter 2024 Financial Results on August 7, 2024 • GlobeNewswire Inc. • 07/31/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/22/2024 08:30:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/15/2024 10:30:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/15/2024 10:27:33 PM
FEATURED Element79 Gold Corp. Reports Significant Progress in Community Relations and Development Efforts in Chachas, Peru • Oct 9, 2024 10:30 AM
Unitronix Corp Launches Share Buyback Initiative • UTRX • Oct 9, 2024 9:10 AM
BASANITE INDUSTRIES, LLC RECEIVES U.S. PATENT FOR ITS BASAFLEX™ BASALT FIBER COMPOSITE REBAR AND METHOD OF MANUFACTURING • BASA • Oct 9, 2024 7:30 AM
BNCM COMPLETES MERGER WITH DELEX HEALTHCARE • BNCM • Oct 8, 2024 9:54 AM
CBD Life Sciences, Inc. (CBDL) Reaches Unprecedented Heights With Explosive Growth and Strategic Expansion in 2024 • CBDL • Oct 8, 2024 8:00 AM
Unitronix Corp. to Invest $3 Million in USA Unity Coin Project • UTRX • Oct 7, 2024 7:08 AM